Development and validation of a proteomic biomarker risk predictor for preterm preeclampsia in asymptomatic women https://www.medrxiv.org/content/10.1101/2022.12.21.22282936
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.